The strongest stocks and groups. RS rating is O'Neil's: 12-month price change with the latest quarter counted double, ranked 1 to 99 against every US stock above $1 trading at least $1M a day.
37 stocks · 3,706 ranked · close of Fri, Nov 20
| Stock | 1M | RS | Ind RS | ADR | ||
|---|---|---|---|---|---|---|
| REPLBiotech | +59.0% | 99 | 96 | Smaller lossSmaller loss | - | 8.8% |
| VCELBiotech | +33.9% | 95 | 89 | +170%▲To profit | +27%▲+23% | 4.9% |
| CGONBiotech | +27.1% | 91▲ | 80 | Bigger lossBigger loss | -4%First sales | 7.9% |
| ADMABiotech | +20.3% | 86 | 70 | +47%▲+14% | +5%▲+2% | 5.4% |
| SRRKBiotech | +14.7% | 56▲ | 48 | Smaller lossSmaller loss | First sales | 5.8% |
| ADPTBiotech | +14.4% | 96 | 90 | -67%Bigger loss | -11%+22% | 6.3% |
| KODBiotech | +13.3% | 99 | 97 | Smaller lossBigger loss | - | 6.7% |
| COAGBiotech | +12.8% | 72▲ | 58 | Smaller lossSmaller loss | - | 8.8% |
| IMVTBiotech | +9.2% | 58▼ | 50 | Smaller lossBigger loss | - | 4.6% |
| KYMRBiotech | +4.0% | 91 | 79 | Bigger lossSmaller loss | -100%+466% | 6.0% |
| VORBiotech | +1.3% | 92▲ | 85 | Smaller lossSmaller loss | - | 6.7% |
| TARSBiotech | +1.3% | 67▼ | 54 | Bigger lossSmaller loss | +64%+69% | 5.4% |
| ICLRBiotech | +0.7% | 92 | 84 | To profit-63% | -3%+1% | 4.1% |
| DNLIBiotech | -1.1% | 42▲ | 43 | To profitSmaller loss | First salesFirst sales | 4.6% |
| MAZEBiotech | -1.8% | 56▼ | 49 | Bigger lossSmaller loss | - | 5.8% |
| MRNABiotech | -3.8% | 99 | 98 | To profitSmaller loss | +29%▲+2% | 8.3% |
| BCRXBiotech | -7.2% | 38 | 39 | +133%+1400% | +13%+34% | 4.5% |
| CRLBiotech | -7.5% | 97 | 91 | +524%▲-103% | -2%-3% | 4.8% |
| RGENBiotech | -8.3% | 76 | 61 | -362%-65% | +11%+12% | 4.7% |
| PCVXBiotech | -11.9% | 61▼ | 51 | Bigger lossBigger loss | - | 4.8% |
| RLAYBiotech | -12.1% | 94 | 87 | Smaller lossBigger loss | - | 6.7% |
| FDMTBiotech | -13.7% | 43▼ | 44 | Bigger lossBigger loss | +4506%+25K% | 8.1% |
| RVMDBiotech | -14.1% | 91 | 77 | Bigger lossBigger loss | First sales | 5.1% |
| BEAMBiotech | -14.9% | 28 | 35 | Bigger lossBigger loss | -97%-94% | 7.6% |
| IMCRBiotech | -17.8% | 26▼ | 30 | Bigger lossSmaller loss | -1%+18% | 4.9% |
| VIRBiotech | -19.6% | 70▼ | 57 | Smaller lossTo profit | -178%+20K% | 6.6% |
| ABSIBiotech | -19.9% | 97 | 92 | Smaller lossSmaller loss | -20%-46% | 11.1% |
| CRSPBiotech | -21.8% | 22 | 25 | Smaller lossSmaller loss | +1325%▲+1041% | 5.6% |
| GLUEBiotech | -22.2% | 10 | 14 | - | +326%▲-61% | 5.8% |
| DNABiotech | -23.2% | 55▼ | 47 | Smaller lossSmaller loss | -6%-49% | 13.4% |
| TWSTBiotech | -23.7% | 98 | 95 | Smaller loss-270% | +28%▲+23% | 11.9% |
| NVAXBiotech | -25.2% | 42▼ | 42 | Smaller loss-152% | -3%-76% | 7.4% |
| IBRXBiotech | -27.6% | 83 | 65 | Bigger lossBigger loss | +52%+94% | 7.9% |
| INBXBiotech | -29.0% | 24▼ | 28 | Bigger lossBigger loss | First sales-100% | 10.3% |
| CADLBiotech | -39.9% | 21 | 23 | Bigger lossBigger loss | - | 9.3% |
| CGEMBiotech | -40.4% | 15 | 19 | - | - | 9.6% |
| IOVABiotech | -51.2% | 98 | 93 | Smaller lossSmaller loss | +80%▲+66% | 8.5% |
RS rating: 0.4 × 3-month + 0.2 × 6-month + 0.2 × 9-month + 0.2 × 12-month return, ranked 1 to 99. Stocks under a year old use the quarters they have. Ind RS ranks the same score among stocks in the same industry. Groups come from SEC SIC codes and need at least 3 stocks. A blue dot means the RS line (price against SPY) is at a 52-week high, a ringed one that it got there before the price. ADR is the 20-day average of high divided by low, minus 1. Updated after each close.
EPS and revenue growth come from the companies' own SEC filings (XBRL): the latest reported quarter against the same quarter a year earlier, with the quarter before under it and ▲ when growth sped up. EPS is diluted GAAP, not the adjusted figure in press releases. There is no percent off a loss or off zero sales; a move to profit or to first sales counts as 0% when sorting and filtering. Q4 is the fiscal year minus Q1 to Q3. Foreign filers (20-F) have no quarterly data. Filings through Sat, Nov 21.